1
|
Wang B, Chu D, Feng Y, Shen Y, Aoyagi-Scharber M, Post LE. Discovery and Characterization of (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1/2 Inhibitor, as an Anticancer Agent. J Med Chem 2015; 59:335-57. [DOI: 10.1021/acs.jmedchem.5b01498] [Citation(s) in RCA: 96] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- Bing Wang
- BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, California 94949, United States
| | - Daniel Chu
- BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, California 94949, United States
| | - Ying Feng
- BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, California 94949, United States
| | - Yuqiao Shen
- BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, California 94949, United States
| | - Mika Aoyagi-Scharber
- BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, California 94949, United States
| | - Leonard E. Post
- BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, California 94949, United States
| |
Collapse
|